Genistein, a predominant isoflavone, has been shown to inhibit the growth of various cancer cells in vitro and in vivo without toxicity to normal cells. In the present study, we investigated the effects of genistein on the activity and the expression of matrix metalloproteinases (MMPs) in MCF-7 and MDA-MB-231 human breast adenocarcinoma cells. Our findings showed that MMP-9 and -2 activation was significantly increased in response to 12-O-tetradecanoyl phorbol-13-acetate (TPA). However, the increased activities of MMP-9 and -2 in TPA-treated cells were concentration-dependently inhibited by treatment with genistein, and this was also correlated with a decrease in the expression of their mRNA and proteins. In addition, a matrigel invasion assay showed that genistein reduced TPA-induced invasion of MCF-7 and MDA-MB-231 cells. Although further in vivo studies are needed, these results suggest that genistein treatment may inhibit tumor cell invasion and, therefore, act as a dietary source to decrease the risk of cancer metastasis. growth factors (fibroblast growth factor-2, epidermal growth factor 및 hepatocyte growth factor), cytokines (tumor necrosis factor-α) 또는 12-O-tetradecanoylphorbol-13-acetate (TPA) 등과 같은 화합물에 의하여 전사 수준에서 발현이 조절 된다 [4,14,32].Genistein은 soy isoflavone의 주요 bioactive component로 서 in vitro 및 in vivo 수준에서 다양한 암세포의 증식을 억제하 는 반면 정상세포에서의 세포독성은 상대적으로 매우 미비한 것으로 알려져 있다[1, 3,5]. 특히 genistein에 의한 암세포의 증 식억제는 암세포의 분화 유도, 세포주기 G2/M arrest 및 apoptosis 유도와 밀접한 연관성이 있는 것으로 알려져 왔다 [8,9,16,[18][19][20]26,33]. 또한 genistein은 유방암을 포함한 어떤 암 세포에서 침윤성(invasive potential)의 억제를 통한 암세포 전